Severe COVID-19 versus multisystem inflammatory syndrome: comparing two critical outcomes of SARS-CoV-2 infection. (2023)
Attributed to:
Optimising Innate Host Defence to Combat Antimicrobial Resistance
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1183/16000617.0197-2022
PubMed Identifier: 36889788
Publication URI: http://europepmc.org/abstract/MED/36889788
Type: Journal Article/Review
Volume: 32
Parent Publication: European respiratory review : an official journal of the European Respiratory Society
Issue: 167
ISSN: 0905-9180